Supplement monograph

Ginkgo

A cognition-positioned botanical where anticoagulant context, seizure history, surgery timing, and extract standardization matter more than memory marketing.

Practical read

Timing is secondary to safety context. Review anticoagulants, antiplatelet drugs, seizure history, surgery plans, and other botanicals before treating ginkgo as a daily cognitive add-on.

Decision frame

Ginkgo: what to check before it earns a slot

Timing rule

Timing is secondary to safety context. Review anticoagulants, antiplatelet drugs, seizure history, surgery plans, and other botanicals before treating ginkgo as a daily cognitive add-on.

Form lens

Standardized leaf extract: most common study contextGinkgo blends: higher interaction-noise riskTea or raw leaf products: weaker dose clarity

Safety lens

Can raise bleeding-risk questions with anticoagulant or antiplatelet therapySeizure history deserves clinician guidanceMemory claims are often broader than the evidence

Best fit

  • Cognition-claim audits
  • Bleeding-risk context review
  • Botanical stack simplification

Form notes

  • Standardized leaf extract: most common study context
  • Ginkgo blends: higher interaction-noise risk
  • Tea or raw leaf products: weaker dose clarity

Watchouts

  • Can raise bleeding-risk questions with anticoagulant or antiplatelet therapy
  • Seizure history deserves clinician guidance
  • Memory claims are often broader than the evidence

Sources and next checks

NCCIH ginkgo overviewMedlinePlus ginkgo precautions
Ginkgo and anticoagulant contextSupplement label auditInteraction checker

Evidence Brief

Get supplement timing and safety notes as they ship.

Monthly evidence briefs. No hype, no disease claims, no influencer supplement stacks.

These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Generated by AI. Always verify with a healthcare professional. Educational information only. Not a substitute for professional medical advice.